6:11 PM
 | 
Sep 25, 2013
 |  BC Extra  |  Company News

MedImmune, UMB in research collaboration

The MedImmune LLC biologics unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) and the University of Maryland, Baltimore entered a five-year research collaboration focused...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >